Erasmus MC Alumni Network

October 8, 2025

Biomarker may predict Parkinson’s disease progression

Researchers at Erasmus MC have discovered a biomarker in the blood that can predict the progression of Parkinson’s disease. ‘Knowing how severe the disease will be in three years allows doctors to plan treatment much more precisely. ’

Read more

July 28, 2025

New Erasmus MC Subsidiary Develops Personalized Immunotherapy

Erasmus MC has established a new company dedicated to developing a new form of immunotherapy. This new therapy — a personalized cancer vaccine — is intended for patients with pancreatic cancer.

Read more

July 23, 2025

New cause found for von Willebrand disease

Scientists at Erasmus MC have discovered that von Willebrand disease, the most common inherited bleeding disorder, is not always caused by a genetic defect in the von Willebrand factor gene. Defects in the mechanisms that control secretion of this hemostatic protein can also cause von Willebrand disease, they show.

Read more

July 16, 2025

Zhenyu wants to know how our brains control movements

Picking up a cup or putting one foot in front of the other: even the simplest movements require a lot of calculations from our brains. Scientist Zhenyu Gao wants to know how this works in the brain. He challenges traditional ideas in the process. ‘Brain parts are not separate lego blocks.’

Read more

June 13, 2025

Integrating immune cells to organoids opens doors for viral research

Scientists at Erasmus MC have succeeded in adding immune cells to organoids of the intestine and liver. This makes these mini-organs even more suitable for research into viral diseases, without the need for laboratory animals.

Read more

May 16, 2025

Discovery of a new syndrome brings answers to hundreds of patients with developmental delay

The discovery of a new syndrome brings an end to the search for a diagnosis for hundreds of patients with an unexplained developmental disorder. “A diagnosis means recognition and acknowledgment.”

Read more